“We can now make Profect liquid protein and our other protein-based products available to a broader spectrum of medical patients”, says Jim Duffy, Protica Research president.
Past News ReleasesRSS
Whitehall, PA (PRWEB) January 10, 2012
Protica, Inc. announced that it has been approved as a Medicare supplier by the Centers for Medicare and Medicaid Services (CMS). Protica Research can now begin making its protein drinks and other medical foods available to Medicare patients for reimbursement.
“Profect protein beverage and our other protein-based products were developed for the healthcare market, so Protica’s alignment with Medicare is a natural fit. We can now make Profect liquid protein and our other protein-based products available to a broader spectrum of medical patients”, says Jim Duffy, Protica Research president.
Profect protein beverage contains Actinase, a patent pending protein formulation developed by Protica and used in dozens of liquid protein products. Actinase is a natural, hypoallergenic, enzymatically-hydrolyzed protein formula. Actinase contains all of the essential amino acids and 100% heat-stable, short-chain peptide proteins (average molecular weight: 1,400 daltons).
More information can be found by visiting Protica’s corporate site at http://www.Protica.com.
Founded in 2001, Protica, Inc. is a research-based nutraceutical firm headquartered in Whitehall, Pennsylvania. In its privately-owned 250,000 square foot facility, Protica manufactures capsulized foods, such as Profect®, Isometric®, Proasis®, and dozens of other brands in ready-to-drink form. To learn more about Protica please visit http://www.protica.com.